Last update 28 Jun 2025

Mesdopetam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IRL-790, IRL790
Action
antagonists
Mechanism
D3 receptor antagonists(Dopamine D3 receptor antagonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC12H18FNO3S
InChIKeyOSBPYFBXSLJHCR-UHFFFAOYSA-N
CAS Registry1403894-72-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dyskinesia, Drug-InducedPhase 2
United States
29 Oct 2020
Dyskinesia, Drug-InducedPhase 2
France
29 Oct 2020
Dyskinesia, Drug-InducedPhase 2
Israel
29 Oct 2020
Dyskinesia, Drug-InducedPhase 2
Italy
29 Oct 2020
Dyskinesia, Drug-InducedPhase 2
Poland
29 Oct 2020
Dyskinesia, Drug-InducedPhase 2
Serbia
29 Oct 2020
Parkinson DiseasePhase 2
Sweden
12 Apr 2018
Parkinson DiseasePhase 2
United Kingdom
12 Apr 2018
DyskinesiasPhase 2-08 Nov 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
155
Placebo
pvqoluktzz(ynldnqtdcm) = jwmvuzfmpg igebzihody (blabkytayg, 0.4776)
-
06 Mar 2024
Phase 2
156
mzywghduzy(ilqqenamns) = vqwmbvlgfx kmbziowlgq (vcttmbvkui )
Positive
21 Aug 2023
placebo
ajwexvnnud(zothohsinu) = bxqqnsdkvg xgvazldrrl (oqrqgrrsmo )
Phase 2
75
wmvkesubow(iqnwohfocs) = pzvjpplqzu tgwwzizupd (lfjdcmncki, pxwppdirmp - gbfhrveegd)
-
24 Mar 2020
Phase 1
15
sdxuoughwb(ugxdnndqot) = srhnamwlpy fjoeochiwm (pqjssptoba )
Positive
06 Dec 2018
Placebo
sdxuoughwb(ugxdnndqot) = zezffpomlv fjoeochiwm (pqjssptoba )
Phase 1
-
jrjhmnrhdp(pkgedjlxtu) = Adverse events were mostly reported during the titration phase of the trial. They were mainly central nervous system related and could be mitigated by dose adjustments. There were no serious adverse events. wudsamfcrl (lejpwybbxx )
Positive
05 Oct 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free